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Summary
Puma encodes a BH3-only protein that is induced by the p53 tumor suppressor and other apoptotic stimuli. To assess its
physiological role in apoptosis, we generated Puma knockout mice by gene targeting. Here we report that Puma is essential
for hematopoietic cell death triggered by ionizing radiation (IR), deregulated c-Myc expression, and cytokine withdrawal.
Puma is also required for IR-induced death throughout the developing nervous system and accounts for nearly all of the
apoptotic activity attributed to p53 under these conditions. These findings establish Puma as a principal mediator of cell
death in response to diverse apoptotic signals, implicating Puma as a likely tumor suppressor.
Introduction expression is regulated not only by p53 through consensus p53-
responsive elements located within its promoter, but also by
The p53 tumor suppressor maintains normal growth control and glucocorticoids and serum deprivation (Han et al., 2001). Puma
genomic stability by enforcing a G1 cell cycle arrest or inducing associates with the mitochondria and induces cell death when
apoptosis in response to DNA damage and other forms of cell overexpressed in various cell lines and its apoptotic activity
stress (Vogelstein et al., 2000). Disruption of this pathway pro- requires an intact BH3 domain. These in vitro studies, as well
motes tumorigenesis, which frequently occurs in human cancers as findings derived from a somatic knockout tumor cell line (Yu
through the inactivation of p53 or its upstream regulators (e.g., et al., 2003), suggested that Puma may play an important role
p19ARF and ATM/ATR). The apoptotic function of p53 is essential as an in vivo regulator of apoptosis.
for its tumor suppressor activity (Schmitt et al., 2002); however,
the mechanism by which p53 physiologically controls cell death Results and Discussion
is ill defined. This response likely depends on p53’s transcrip-
tional regulation of target genes that now includes 70 candi- To examine the physiological contribution of Puma to apoptosis,
dates, half of which have a purported activity in triggering apo- we generated Puma-deficient mice by deleting exons 1–3, which
ptosis. It also has been proposed that no single gene may includes the transcription and translation start sites and the
account for p53-dependent apoptosis and that combinations entire BH3 domain (Figure 1). Puma/ animals were identified
of targets may be required in a coordinated manner to elicit an using PCR and Southern blot analysis (Figure 1B and data not
apoptotic signal (Zhao et al., 2000). shown) and bred to generate homozygous mutant mice. Viable
Recent interest in how p53 triggers cell death has focused Puma/ mice were obtained and no obvious developmental
on Puma/Bbc3 (p53 upregulated modulator of apoptosis/Bcl-2 defects were evident (Figure 1C). Western blot and real-time
binding component-3; referred to hereafter as Puma), a BH3- PCR analysis demonstrated that Puma is not expressed in he-
only proapoptotic Bcl-2 family member. Puma was identified matopoietic cells derived from these knockout mice (Figure 1D
as a p53-inducible gene by differential expression analyses and and Supplemental Figure S2 at http://www.cancercell.org/cgi/
as a Bcl-2 binding protein in a yeast two-hybrid screen (Nakano content/full/4/4/321/DC1).
and Vousden, 2001; Yu et al., 2001; Han et al., 2001). One Induction of DNA damage in primary thymocytes by -irradi-
ation (-IR) provokes rampant apoptosis (Lowe et al., 1993;feature that sets Puma apart from other p53 targets is that Puma
S I G N I F I C A N C E
The p53 tumor suppressor protects against cancer by eliminating cells that have suffered DNA damage or proliferate in an uncontrolled
manner, by inducing apoptosis. We describe here the mechanism by which p53 elicits cell death and show that this occurs through
the induction of Puma, a BH3-only proapoptotic protein. The establishment of Puma as an essential mediator of p53-dependent
apoptosis reveals a novel target that could be exploited for either sensitizing or conferring resistance to chemo- and radiation-
based therapies.
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Figure 1. Generation of Puma-deficient mice
A: Genomic structure of the Puma locus and the
targeting scheme for generating Puma/ mice.
B: PCR-based genotyping of WT and Puma-
deficient animals.
C: Genotyping results of litters derived from
Puma/ crosses at weaning.
D: Western blot analysis of Puma expression in
primary myeloid progenitors derived from WT
and Puma/ mice (NS, nonspecific band).
Clarke et al., 1993). Susceptibility to cell death following DNA fact that p53 was efficiently induced in Puma/ cells (Figure
2). Puma/ thymocytes displayed an intermediate apoptoticdamage specifically requires p53, as p53/ thymocytes are
resistant to -IR yet readily undergo apoptosis in response to response, suggesting that Puma is rate limiting in this process.
Puma/ thymocytes were also refractory to Dex-induced apo-other stimuli such as glucocorticoids. Thymocyte apoptosis can
therefore occur through at least two distinct pathways: (1) a ptosis when compared to WT and p53 null cells, but ultimately
underwent cell death by 46 hr (Figure 2 and Supplemental FigureDNA damage-induced response, which requires an intact p53
pathway; and (2) a glucocorticoid-mediated process that is inde- S1 on Cancer Cell website). The partial sensitivity of Puma/
thymocytes to Dex suggests that additional factors participatependent of p53 status. Since Puma expression is induced by
p53 as well as glucocorticoids, the role of Puma in these pro- in a redundant manner in triggering this cell death response. One
such candidate is Bim, a BH3-only protein whose expression iscesses was addressed by preparing thymocytes from wild-type
(WT), Puma/ and Puma/ littermates at 6–7 weeks of age. also induced by dexamethasone (Wang et al., 2003). Similar to
the Puma knockout, loss of Bim provides a partial protectionThe cells were placed in culture and divided into three groups:
(1) control; (2) dexamethasone (1 M, Dex); and (3) DNA damage against Dex at earlier times but not at later times (Supplemental
Figure S1 online). Although Bim had also been reported to con-(5 Gy, -IR). Samples were harvested at specific intervals follow-
ing treatment and cell viability assessed by propidium iodide tribute to IR-induced thymocyte apoptosis (Bouillet et al., 1999),
Bim deficiency had little effect on the survival of thymocytesstaining and FACS analysis (Figure 2). As expected, -IR effi-
ciently induced p53 expression and the death of WT thymo- following -IR, especially when compared to Puma/ cells (Fig-
ure 2 and Supplemental Figure S1 on Cancer Cell website). Ascytes. Strikingly, Puma/ thymocytes maintained viability that
equaled the survival of p53/ cells following -IR despite the expected (Knudson et al., 1995), Bax-deficient thymocytes were
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Figure 2. Puma-deficient thymocytes are resis-
tant to DNA damage-induced apoptosis
Thymocytes from 6-week-old mice were
placed in culture and treated with either 1 M
dexamethasone (Dex), 5 Gy ionizing radiation
(-IR), or vehicle-only (control) for the indicated
times.
A: Two hours following treatment, cells were har-
vested and analyzed for p53 expression by West-
ern blot analysis in Control (lanes 1, 4, 7, 10, and
13), Dex (lanes 2, 5, 8, 11, and 14), and -IR-
treated (lanes 3, 6, 9, 12, and 15) samples.
B: Sixteen hours following treatment, cells were
harvested and analyzed for viability by propid-
ium iodide staining and FACS analysis. Apoptotic
cells exhibited sub-G1 DNA (light blue) and via-
ble cells displayed G1 and G2 DNA content
(red).
C: Quantitation of cell death in response to -IR.
Results are representative from two independent
experiments.
also sensitive to -IR and underwent massive cell death (Figure was also explored in the whole animal (Figure 3). Postnatal day
5 (P5) WT and Puma-deficient littermates were exposed to 182C). The resistance to -IR-induced apoptosis was also evident
in Puma-deficient myeloid progenitors and B cells (Supplemen- Gy -IR and allowed to recover for 6 hr. Tissues were collected
and analyzed for cell death by morphological and TUNEL-basedtal Figures S3 and S4 online). Thus, Puma is a critical physiologi-
cal mediator of p53-induced apoptosis of primary thymocytes assays. As observed in p53/ mice, there was an almost com-
plete abrogation of radiation-induced apoptosis in the thymusin response to DNA damage and contributes to glucocorticoid-
mediated cell death. of Puma null animals after -IR (Figures 3e and 3f). Consistent
with our ex vivo findings, apoptosis was compromised in theThe role of Puma in DNA damage-induced death in the
thymus, as well as throughout the developing nervous system, Puma/ thymus compared to WT, although cell death was
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Figure 3. Puma is required for -IR-induced apo-
ptosis in vivo in the thymus and nervous system
Top panels: Puma mediates p53-dependent
death in the thymus following -IR. Abundant
apoptosis in WT thymus (b), but markedly re-
duced apoptosis in the Puma/ thymus (c) was
identified using TUNEL staining 6 hr after 18 Gy of
-IR. Puma/ (f) or p53/ (e) thymi display an
almost complete resistance to -IR-induced
apoptosis. Basal levels of apoptosis in unirradi-
ated p53/ (d) and WT (a) thymi are also shown.
Bottom panels: -IR-induced apoptosis in the de-
veloping CNS is mediated by Puma. Widespread
IR-induced apoptosis was, as expected, obvious
in the cerebellar external granule layer (g and
k), the dentate gyrus (h and l), the retina (i and
m), and the subventricular zone of the lateral
ventricle (j and n) of WT mice. By contrast,
Puma/ tissues were highly resistant to -IR-
induced apoptosis (o–v). Apoptosis was de-
tected by neutral red staining (g–j and o–r) or
TUNEL (k–n and s–v). Arrows indicate pyknotic
cells. Magnification is 400.
substantially higher than in the Puma/ thymus (Figures 3b, 3c, tricular zone (SVZ) of the lateral ventricle of Puma/ animals
were highly resistant to apoptosis, as judged by the absenceand 3f). Exposure of the developing nervous system to ionizing
radiation also leads to p53-dependent apoptosis in proliferating of pyknotic figures (Figures 3o–3r), whereas extensive cell death
occurred in WT tissues (Figures 3g–3j). Histological identificationand immature cell populations (Herzog et al., 1998). Remarkably,
Puma deficiency completely blocked cell death throughout the of pyknotic cells as being apoptotic was confirmed by TUNEL
analysis, which revealed pronounced and widespread apoptosisdeveloping nervous system following -IR treatment (Figure 3).
Specifically, the cerebellar external granule layer (EGL), the den- in all -IR-treated WT CNS regions examined (Figures 3k–3n),
while there were virtually no TUNEL-positive cells in the -IR-tate gyrus (DG) of the hippocampus, the retina, and the subven-
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Figure 4. Puma is required for p53-dependent
and -independent cell death signals
Primary bone marrow-derived myeloid stem cells
were expanded in medium containing IL-3, IL-6,
and SCF.
A: Puma mediates the p53 apoptotic check-
point triggered by Myc. Primary myeloid progeni-
tors were engineered to express a puromycin-
resistance marker alone (Puro) or Puro and the
conditional Myc-ER transgene. Levels of Myc ex-
pression and activity were equivalent between
each genotype as demonstrated by Western
blot analysis for Myc-ER and the induction of
p21Cip1 following 4-HT treatment (lower panel:
lanes 1, 3, and 5, Puro-only; lanes 2, 4, and 6, Myc-
ER). Viability was determined after activation of
Myc-ER with 4-HT at the indicated times by trypan
blue dye exclusion. Key: , WT; , Puma/; ,
Puma/; closed symbols, Puro-only; open sym-
bols, Myc-ER. Data shown represent three inde-
pendent experiments.
B: The intrinsic apoptotic response to cytokine
withdrawal is mediated by Puma. Cells were
maintained in media containing 10% serum with
and without cytokine for the indicated times and
viability was determined by FACS and trypan
blue dye exclusion. Data represent the average
of five independent experiments using primary
WT and Puma-deficient cell cultures.
treated Puma/ CNS (Figures 3s–3v). Therefore, Puma is essen- ern blot analysis demonstrated that the expression of Myc-ER
was equivalent in WT, Puma/ and Puma/ cells (Figure 4A).tial for apoptosis in the thymus and developing postnatal CNS
after -IR and Puma loss recapitulates the radiation resistance Activation of Myc-ER in WT myeloid progenitors induced mas-
sive cell death (10% survived at 96 hr), whereas Puma/ cellsobserved in p53 knockout mice.
Inappropriate cell proliferation stimulated by oncogenes trig- were highly resistant and more than 50% of the population
remained viable (Figure 4A). In fact, Puma null cells are compara-gers p53-dependent apoptosis of hematopoietic cells (Eischen et
al., 1999; Schmitt et al., 1999), and the engagement of this cell ble to p53/ myeloid cells in their response to Myc-induced
apoptosis (Eischen et al., 1999 and data not shown). Similarly,death pathway provides a mechanism to eliminate potential
cancer cells and suppress tumor development (Schmitt et al., Puma/ murine embryo fibroblasts, like p53/ cells, were re-
sistant to c-Myc-induced apoptosis (Supplemental Figure S52002). The contribution of Puma to oncogene-induced apopto-
sis was examined by conditionally activating c-Myc fused to the on Cancer Cell website). Therefore, Puma also functions as an
essential apoptotic regulator that protects against hyperprolifer-4-hydroxytamoxifen (4-HT)-responsive domain of the estrogen
receptor (ER) in primary myeloid progenitors (Figure 4A). West- ative signals emanating from oncogenes, such as c-Myc.
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Primitive bone marrow-derived myeloid progenitors require apoptotic p53-regulated genes, the loss of just Puma having
such a profound effect on apoptosis after DNA damage andinterleukin-6 (IL- 6), IL-3, and stem cell factor (SCF) for growth
and survival (Packham et al., 1998). Removal of these cytokines other apoptotic stimuli is quite remarkable. Indeed, Puma is as
essential to the induction of apoptosis during DNA damage asleads to G1 cell cycle arrest followed by protracted apoptosis,
and this intrinsic cell death response is p53 independent (Pack- p21Cip1 is to p53-dependent cell cycle arrest (Deng et al., 1995).
The contribution of PUMA to cell death was recently as-ham et al., 1998; Eischen et al., 2001). Cytokine deprivation
generally results in reduced expression of most genes; however, sessed in somatic knockout cancer cells (Yu et al., 2003). Homo-
zygous deletion of PUMA in human colon carcinoma HCT116one exception is Bim, which is induced under these conditions
(Shinjyo et al., 2001). Initial studies relying on 32D myeloid pro- cells that had been previously targeted to not express p21CIP1
renders these double-knockout cancer cells resistant to p53-genitor cells revealed that IL-3 suppresses Puma mRNA and
protein levels (data not shown). To properly assess the role mediated apoptosis. It was also shown that BAX null HCT1166
cells are completely resistant to overexpression of PUMA, plac-of Puma in cytokine withdrawal-induced death, primary bone
marrow was obtained from the femurs of WT, Puma/ and ing BAX downstream of PUMA and demonstrating a strict re-
quirement for BAX in PUMA-mediated cell death. One limitationPuma/ mice and cultured short term in medium containing
IL-3, IL-6, and SCF to expand primary myeloid progenitor cells of this approach, however, is the reliance on tumor cells that
have obviously undergone multiple genetic alterations. By spe-(CD34, c-Kit, Sca1, Lin, data not shown). Real-time PCR
analysis demonstrated that Puma expression is induced 7- to cifically targeting Puma in mice, primary cells of different tissue
8-fold in primary myeloid cells following cytokine withdrawal types can be readily analyzed in vivo and ex vivo without the
(Supplemental Figure S2 online). Consequently, WT progenitors complication of additional genetic hits. Using this strategy, we
progressively lost viability when deprived of cytokines and by demonstrated that (1) Puma is required for -IR-induced death
day 3 only 10%–15% of these cells were viable (Figure 4B of thymocytes and that Bax is dispensable for this response
and data not shown). Similarly, p53-deficient cells were only (Figure 2) and (2) Puma is essential for -IR-induced apoptosis
modestly resistant to cytokine deprivation. Consistent with pre- throughout the developing CNS (Figure 3), including the retina,
vious findings (Bouillet et al., 1999), Bim-deficient cells exhibited which does not require Bax (Chong et al., 2000). Thus, Puma is
extended survival in media lacking cytokines, but ultimately required for apoptosis in cell types and under stress conditions
underwent cell death, and by day 7 less than 10% of these cells where Bax is dispensable.
were viable (Figure 4B). By contrast, nearly 90% of the Puma/ Interestingly, recent studies demonstrate that tumors can
myeloid progenitors survived for 3 days in the absence of cyto- tolerate wild-type p53 if appropriate survival measures are im-
kines, and even after one week, approximately 50% of these plemented, such as enforced Bcl-2 expression, indicating that
cells remained viable (Figure 4B and data not shown). Neverthe- p53s apoptotic activity is its primary tumor suppressor function
less, Puma/ progenitors remained dependent on cytokines (Schmitt et al., 2002). Our results are not entirely consistent with
for growth and arrested in G1 phase when deprived of hemo- this notion and suggest that the combined activities of p53 cell
poietins (data not shown). Therefore, in contrast to p53, Puma cycle arrest and cell death serve as checkpoints in cancer.
plays an important role in the intrinsic cell death response sup- Consistent with this hypothesis, Puma knockout mice do not
pressed by survival factors. appear to be inherently predisposed to developing spontaneous
Although Puma null thymocytes, myeloid progenitors, and tumors. Presently, there are 14 Puma/ mice over the age of
pro-B lymphocytes are remarkably resistant to apoptosis due 6 months (including animals that are over 1 year of age), which
to DNA damage, glucocorticoids, and/or limiting concentrations is well beyond the time frame for tumor development in p53
of cytokines, Puma does not appear to play a significant role knockout mice. Indeed, the only tumor-related death that we
in normal hematopoietic development. All lymphoid and myeloid have observed within the entire Puma colony was a Puma/
subtypes, including those found in the bone marrow, thymus, mouse at 8 months of age that developed medulloblastoma,
spleen, and peripheral lymph nodes, are present and maintained which is not observed in p53 knockout mice unless bred onto
at normal levels in Puma knockout mice (Supplemental Figure other genetically deficient backgrounds (e.g., Ptc1/) (Wetmore
S6 on Cancer Cell website). A likely explanation for these find- et al., 2001). Whether tumor incidence increases in aged Puma-
ings is that similar to p53, Puma may contribute to cell death deficient mice, or in cooperation with other genetically predis-
within these cell types only during pathological stress re- posing alterations, is currently being examined.
sponses.
Our results demonstrate that Puma is a critical mediator of Experimental procedures
p53-induced cell death and actually accounts for nearly all of
Generation of Puma-deficient micethe apoptotic activity attributed to p53 in primary hematopoietic
A 16.9 Kb EcoRI fragment encompassing the entire Puma gene was isolatedcells and the CNS in response to -IR or oncogenes (c-Myc).
from an ES 129/SvJ BAC library (Incyte Genomics) and subcloned into
Recent studies have suggested a model whereby p53 promotes pGEM-3Z. A portion of the 5 promoter region, transcription start site, and
cell death by directly forming complexes with Bcl-2 and Bcl-XL 85% of the coding region were deleted by digestion with NotI and AscI and
at the mitochondria (Mihara et al., 2003; Dumont et al., 2003). substituted with a 1.1 Kb XhoI–XbaI fragment of Neo-Poly A. E14 embryonic
stem cells were electroporated with the linearized Puma targeting vector,By contrast, our findings demonstrate that endogenous wild-
selected in G418, and properly recombined clones were microinjected intotype p53 is not sufficient in the absence of Puma to induce
C57BL/6 blastocysts. Germline transmission was achieved and hemizygousefficient cell death. Rather, Puma is required for p53-mediated
animals were identified by PCR and Southern blot analyses. The primer paircell death and this most likely occurs through the direct tran-
for amplification of the WT allele was Puma a (5-TTATAGCCGGTGAGTGCA-
scriptional induction of Puma expression by p53 and the subse- 3) and Puma b (5-AACAGCTTATTAAGAGCCAGCC-3). The primer pair for
quent association of Puma with Bcl-2 family members at the amplification of the mutant allele was Puma c (5-TTGACGAGTTCTTCT
GAGGG-3) and Puma b. Southern blot analysis was performed after XmnImitochondria. In light of the significant number of putative pro-
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digestion using an outside probe (218 bp PCR-generated fragment located and CA71907 (G.P.Z.), DK44158 and CA76379 (J.L.C.), NS37956 and
NS39867 (P.J.M.), DK42932 (J.N.I), Cancer Center CORE Grant CA21765,3 to the targeting vector).
and by the American Lebanese Syrian Associated Charities (ALSAC).
Cell cultures
Thymocytes were prepared from 6-week-old animals by passing the cells
through a 100 M sterile nylon mesh into DMEM containing 5% fetal bovine
serum (FBS), 1% L-Glutamine, 1% penicillin/streptomycin, and 25 mM Received: September 25, 2003
HEPES at 1  106 cells/ml. The cells were cultured at 37C under 5% CO2 Revised: September 26, 2003
and either treated with 1 M dexamethasone or 5 Gy -irradiation. Myeloid Published online: October 1, 2003
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